The peptide binding specificity of the MHC class II I-A molecule of the Lewis rat, RT1.BI.
暂无分享,去创建一个
H. Rammensee | M. Eisenstein | H. Schild | I. Cohen | B. Reizis | F. Mor | S. Stefanovic
[1] G. Nepom,et al. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. , 1996, Journal of immunology.
[2] E. Thorsby,et al. Identification of a putative motif for binding of peptides to HLA-DQ2. , 1996, International immunology.
[3] R. Karr,et al. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[4] H. Rammensee,et al. Natural ligand motifs of H-2E molecules are allele specific and illustrate homology to HLA-DR molecules. , 1995, International immunology.
[5] Partho Ghosh,et al. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.
[6] J. Drijfhout,et al. Clip binds to HLA class II using methionine-based, allele-dependent motifs as well as allele-independent supermotifs. , 1995, Molecular immunology.
[7] R. Karr,et al. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association , 1995, The Journal of experimental medicine.
[8] H. Rammensee,et al. Chemistry of peptides associated with MHC class I and class II molecules. , 1995, Current opinion in immunology.
[9] A Sette,et al. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II , 1995, The Journal of experimental medicine.
[10] V. Gnau,et al. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules , 1995, The Journal of experimental medicine.
[11] L. Steinman,et al. Escape from “horror autotoxicus”: Pathogenesis and treatment of autoimmune disease , 1995, Cell.
[12] H. Mcdevitt,et al. Binding of an invariant-chain peptide, CLIP, to I-A major histocompatibility complex class II molecules. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[13] 小島 公一. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia , 1995 .
[14] Z. Nagy,et al. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning , 1994, The Journal of experimental medicine.
[15] H. Lassmann,et al. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia , 1994, The Journal of experimental medicine.
[16] H. Rammensee,et al. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. , 1994, Journal of immunology.
[17] W. Hickey,et al. Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. The utility of a class II binding motif in selecting self-reactive peptides. , 1994, Journal of immunology.
[18] W. Hickey,et al. Identification of an N-terminally acetylated encephalitogenic epitope in myelin proteolipid apoprotein for the Lewis rat. , 1994, Journal of Immunology.
[19] D. Zaller,et al. Prediction of peptide affinity to HLA DRB1*0401. , 1994, International archives of allergy and immunology.
[20] W. van Eden,et al. CDR1 T-cell receptor beta-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Rothbard,et al. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. , 1994, Journal of immunology.
[22] S. Buus,et al. Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules , 1994, International immunology.
[23] M. Davis,et al. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). , 1994, Journal of immunology.
[24] Don C. Wiley,et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.
[25] C. Janeway,et al. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. , 1994, Journal of immunology.
[26] I. Cohen,et al. Autoimmune disease models : a guidebook , 1994 .
[27] D. Wiley,et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.
[28] F. Sinigaglia,et al. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries , 1992, The Journal of experimental medicine.
[29] H. Lassmann,et al. Cell adhesion molecules of the immunoglobulin supergene family as tissue‐specific autoantigens: induction of experimental allergic neuritis (EAN) by PO protein‐specific T cell lines , 1992, European journal of immunology.
[30] I. Cohen,et al. Induction of experimental autoimmune encephalomyelitis by native myelin basic protein‐activated T lymphocyte lines , 1992, European journal of immunology.
[31] G. Adamus,et al. Specificity of T and B cell responses to bovine rhodopsin in Lewis rats. , 1991, Cellular immunology.
[32] D. Wiley,et al. Peptide binding to HLA‐DR1: a peptide with most residues substituted to alanine retains MHC binding. , 1990, The EMBO journal.
[33] G. Flouret,et al. The N- and C-terminal boundaries of myelin basic protein determinants required for encephalitogenic and proliferative responses of Lewis rat T cells , 1990, Journal of Neuroimmunology.
[34] T. Olee,et al. A T cell epitope for experimental allergic neuritis , 1988, Journal of Neuroimmunology.
[35] J. Lindstrom,et al. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides. , 1988, Journal of immunology.
[36] I. Cohen,et al. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis , 1988, Nature.
[37] A Sette,et al. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides , 1987, Science.
[38] I. Cohen,et al. Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. , 1984, The Journal of clinical investigation.